Maximum Safe Duration for Metoclopramide in Chronic Nausea

Neurologic Risk and Clinical Management

The National Comprehensive Cancer Network guidelines state that chronic use of metoclopramide may be limited due to concern for neurologic complications, including tardive dyskinesia, a potentially irreversible movement disorder 1, 2
For chronic nausea, the American Gastroenterological Association recommends starting with 10 mg metoclopramide 30 minutes before each meal and at bedtime (four times daily) for a minimum of 4 weeks to constitute an adequate trial, with doses supported by the FDA label 3
After 1 week of metoclopramide therapy, if nausea persists, the National Comprehensive Cancer Network and American Society of Clinical Oncology recommend reassessing the cause of nausea and considering adding therapies targeting different mechanisms, rather than simply increasing metoclopramide 2, 4, 5

The European Society of Gastrointestinal Motility recommends considering domperidone, a peripheral D2 dopamine receptor antagonist, for long-term therapy, though it requires QTc monitoring due to cardiac risks, as an alternative to metoclopramide 6